|
December 13-14, 2001 Meeting
Date and Time:
The meeting will be held on December 13, 2001, 8:00 a.m. to 5:30 p.m., and December 14, 2001, 8:00 a.m. to 3:30 p.m.
Location:
Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910, 301-589-5200
Contact:
Linda A. Smallwood, Ph.D., 301-827-3514, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 19516. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On December 13, 2001, the following committee updates are tentatively scheduled: transmissible spongiform encephalopathies (TSE) guidance, CDC workshop on factor VIII, update on disaster response, and compliance quality control oversight. In the morning, the committee will hear presentations, discuss and make recommendations on potential concerns for simian foamy virus (SFV) transmission by blood and blood products. In the afternoon, the committee will hear presentations, discuss and make recommendations on the leukocyte reduction guidance. On December 14, 2001, the committee will hear presentations, discuss and make recommendations on human cells, tissues and cellular and tissue-based products: risk factors for semen donation.
Oral Presentations:
Between approximately 12 noon and 12:30 p.m., and 3:45 and 4:45 p.m. on December 13, 2001; and 11:30 a.m. and 1:00 p.m. on December 14, 2001 oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before December 3, 2001.
|
